150 related articles for article (PubMed ID: 19800763)
1. Consideration of strategies for hematopoietic cell transplantation.
Yaniv I; Ash S; Farkas DL; Askenasy N; Stein J
J Autoimmun; 2009; 33(3-4):255-9. PubMed ID: 19800763
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
4. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
[TBL] [Abstract][Full Text] [Related]
5. Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
Kline J; Subbiah S; Lazarus HM; van Besien K
Bone Marrow Transplant; 2008 Mar; 41(6):505-13. PubMed ID: 18026144
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect.
Van Wijmeersch B; Sprangers B; Rutgeerts O; Lenaerts C; Landuyt W; Waer M; Billiau AD; Dubois B
Biol Blood Marrow Transplant; 2007 Jun; 13(6):627-37. PubMed ID: 17531772
[TBL] [Abstract][Full Text] [Related]
7. Stem cell transplantation for severe autoimmune diseases: progress and problems.
Marmont AM
Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
[TBL] [Abstract][Full Text] [Related]
8. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
Michallet M; Dhedin N; Michallet AS
Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
[TBL] [Abstract][Full Text] [Related]
9. Tweaking the immune system: gene therapy-assisted autologous haematopoietic stem cell transplantation as a treatment for autoimmune disease.
Alderuccio F; Chan J; Toh BH
Autoimmunity; 2008 Dec; 41(8):679-85. PubMed ID: 18958752
[TBL] [Abstract][Full Text] [Related]
10. The combination of stem cell transplantation and immunotherapy: future potential.
Talmadge JE
In Vivo; 1994; 8(5):675-90. PubMed ID: 7727713
[TBL] [Abstract][Full Text] [Related]
11. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
Resnick IB; Shapira MY; Slavin S
Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
[TBL] [Abstract][Full Text] [Related]
12. [Immunoablation or otherwise followed by hematopoietic cell stem as intensive treatment of severe autoimmune diseases].
du Haut Champ AM
Ann Ital Med Int; 2002; 17(1):11-20. PubMed ID: 11975110
[TBL] [Abstract][Full Text] [Related]
13. Autologous stem cell transplantation in autoimmune diseases.
Passweg J; Tyndall A
Semin Hematol; 2007 Oct; 44(4):278-85. PubMed ID: 17961728
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity following haematopoietic stem-cell transplantation.
Daikeler T; Tyndall A
Best Pract Res Clin Haematol; 2007 Jun; 20(2):349-60. PubMed ID: 17448966
[TBL] [Abstract][Full Text] [Related]
15. Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases.
Marmont AM
J Rheumatol Suppl; 1997 May; 48():13-8. PubMed ID: 9150112
[TBL] [Abstract][Full Text] [Related]
16. Engineering mesenchymal stem cells for immunotherapy.
Jorgensen C; Djouad F; Apparailly F; Noël D
Gene Ther; 2003 May; 10(10):928-31. PubMed ID: 12732877
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
Vossen J
Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
[TBL] [Abstract][Full Text] [Related]
18. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases.
Hinterberger W; Hinterberger-Fischer M; Marmont A
Bone Marrow Transplant; 2002 Dec; 30(11):753-9. PubMed ID: 12439698
[TBL] [Abstract][Full Text] [Related]
19. Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease.
Tyndall A; Fassas A; Passweg J; Ruiz de Elvira C; Attal M; Brooks P; Black C; Durez P; Finke J; Forman S; Fouillard L; Furst D; Holmes J; Joske D; Jouet J; Kötter I; Locatelli F; Prentice H; Marmont AM; McSweeney P; Musso M; Peter HH; Snowden JA; Sullivan K; Gratwohl A
Bone Marrow Transplant; 1999 Oct; 24(7):729-34. PubMed ID: 10516675
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures.
Karussis D; Slavin S
J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
